Share
𝕏 Facebook LinkedIn

Randomised, placebo-controlled trial of transcranial pulsed EMF in patients with multiple chemical sensitivity

PAPER manual 2016 Randomized trial Effect: mixed Evidence: Moderate

Abstract

Randomised, placebo-controlled trial of transcranial pulsed EMF in patients with multiple chemical sensitivity Tran MT, Skovbjerg S, Arendt-Nielsen L, Christensen KB, Elberling J. A randomised, placebo-controlled trial of transcranial pulsed electromagnetic fields in patients with multiple chemical sensitivity. Acta Neuropsychiatr. 2016 Dec 6:1-11. Abstract OBJECTIVE: To evaluate the efficacy of transcranially applied pulsed electromagnetic fields (PEMF) on functional impairments and symptom severity in multiple chemical sensitivity (MCS) patients. METHODS: The study was conducted as a nationwide trial in Denmark using a randomised, parallel-group, double-blind and placebo-controlled design. Sample size was estimated at 40 participants. Eligibility criteria were age 18-75 years and fulfilment of the MCS case criteria. Participants received either PEMF or placebo PEMF (no stimulation) applied transcranially for 6 weeks. The primary outcome was the Life Impact Scale (LIS) of the Quick Environmental Exposure and Sensitivity Inventory (QEESI). Secondary outcomes were the Symptom Severity Scale (SSS) and the Chemical Intolerance Scale of QEESI. RESULTS: A total of 39 participants were randomised to PEMF or placebo treatment. No significant difference was observed on QEESI LIS between groups with a mean change score of -5.9 in the PEMF group compared with -1.5 in the placebo group (p=0.35, effect size=-0.31). However, a significant decrease was detected on QEESI SSS within and between groups with a mean change score of -11.3 in the PEMF group compared with -3.2 in the placebo group (p=0.03, effect size=-0.60). CONCLUSION: PEMF treatment of 6 weeks showed no effect on functional impairments in MCS. However, a significant decrease in symptom severity was observed. ncbi.nlm.nih.gov

AI evidence extraction

At a glance
Study type
Randomized trial
Effect direction
mixed
Population
Patients with multiple chemical sensitivity (MCS), age 18–75 years (Denmark)
Sample size
39
Exposure
transcranial pulsed electromagnetic fields (PEMF) · 6 weeks
Evidence strength
Moderate
Confidence: 78% · Peer-reviewed: yes

Main findings

In 39 randomized MCS patients treated for 6 weeks, there was no significant between-group difference on QEESI Life Impact Scale (mean change -5.9 PEMF vs -1.5 placebo; p=0.35; effect size=-0.31). Symptom severity (QEESI SSS) decreased significantly within and between groups (mean change -11.3 PEMF vs -3.2 placebo; p=0.03; effect size=-0.60).

Outcomes measured

  • Functional impairments (QEESI Life Impact Scale, LIS)
  • Symptom severity (QEESI Symptom Severity Scale, SSS)
  • Chemical intolerance (QEESI Chemical Intolerance Scale)

Limitations

  • Small sample size (39 randomized; sample size estimated at 40)
  • Frequency/dose parameters of PEMF not reported in abstract
  • Chemical Intolerance Scale results not reported in abstract
View raw extracted JSON
{
    "study_type": "randomized_trial",
    "exposure": {
        "band": null,
        "source": "transcranial pulsed electromagnetic fields (PEMF)",
        "frequency_mhz": null,
        "sar_wkg": null,
        "duration": "6 weeks"
    },
    "population": "Patients with multiple chemical sensitivity (MCS), age 18–75 years (Denmark)",
    "sample_size": 39,
    "outcomes": [
        "Functional impairments (QEESI Life Impact Scale, LIS)",
        "Symptom severity (QEESI Symptom Severity Scale, SSS)",
        "Chemical intolerance (QEESI Chemical Intolerance Scale)"
    ],
    "main_findings": "In 39 randomized MCS patients treated for 6 weeks, there was no significant between-group difference on QEESI Life Impact Scale (mean change -5.9 PEMF vs -1.5 placebo; p=0.35; effect size=-0.31). Symptom severity (QEESI SSS) decreased significantly within and between groups (mean change -11.3 PEMF vs -3.2 placebo; p=0.03; effect size=-0.60).",
    "effect_direction": "mixed",
    "limitations": [
        "Small sample size (39 randomized; sample size estimated at 40)",
        "Frequency/dose parameters of PEMF not reported in abstract",
        "Chemical Intolerance Scale results not reported in abstract"
    ],
    "evidence_strength": "moderate",
    "confidence": 0.7800000000000000266453525910037569701671600341796875,
    "peer_reviewed_likely": "yes",
    "keywords": [
        "randomised",
        "placebo-controlled",
        "double-blind",
        "parallel-group",
        "transcranial",
        "pulsed electromagnetic fields",
        "PEMF",
        "multiple chemical sensitivity",
        "QEESI",
        "Life Impact Scale",
        "Symptom Severity Scale",
        "Denmark"
    ],
    "suggested_hubs": []
}

AI can be wrong. Always verify against the paper.

AI-extracted fields are generated from the abstract/metadata and may be incomplete or incorrect. This content is for informational purposes only and is not medical advice.

Comments

Log in to comment.

No comments yet.